Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It?

PAHC's 59% YTD surge rides on strong Animal Health momentum, booming vaccines and global gains despite the rising competition.

Zacks Investment Research • Dec 10, 2025

Best Growth Stocks to Buy for December 9th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 9th:

Zacks Investment Research • Dec 9, 2025

Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why

Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research • Dec 8, 2025

PAHC vs. BSX: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Dec 8, 2025

Why Is Phibro (PAHC) Down 5.3% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Dec 5, 2025

Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Dec 3, 2025

3 Momentum Anomaly Stocks to Buy as Markets Gear Up for 2025 Swansong

Amid volatile markets, AGX, UI and PAHC show strong long-term momentum despite recent pullbacks.

Zacks Investment Research • Dec 3, 2025

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Nov 27, 2025

Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Nov 25, 2025

Phibro (PAHC) Upgraded to Strong Buy: Here's What You Should Know

Phibro (PAHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Nov 20, 2025